Crossref journal-article
American Association for the Advancement of Science (AAAS)
Science (221)
Abstract

Repeated administration of morphine sensitizes animals to the stimulant and rewarding properties of the drug. It also selectively increases expression of GluR1 (an AMPA glutamate receptor subunit) in the ventral tegmental area, a midbrain region implicated in morphine action. By viral-mediated gene transfer, a causal relation is shown between these behavioral and biochemical adaptations: Morphine's stimulant and rewarding properties are intensified after microinjections of a viral vector expressing GluR1 into the ventral tegmental area. These results confirm the importance of AMPA receptors in morphine action and demonstrate specific locomotor and motivational adaptations resulting from altered expression of a single localized gene product.

Bibliography

Carlezon, W. A., Boundy, V. A., Haile, C. N., Lane, S. B., Kalb, R. G., Neve, R. L., & Nestler, E. J. (1997). Sensitization to Morphine Induced by Viral-Mediated Gene Transfer. Science, 277(5327), 812–815.

Authors 7
  1. William A. Carlezon (first)
  2. Virginia A. Boundy (additional)
  3. Colin N. Haile (additional)
  4. Sarah B. Lane (additional)
  5. Robert G. Kalb (additional)
  6. Rachael L. Neve (additional)
  7. Eric J. Nestler (additional)
References 46 Referenced 213
  1. Vezina P., Stewart J., Brain Res. 499, 108 (1989); (10.1016/0006-8993(89)91140-2) / Brain Res. by Vezina P. (1989)
  2. ; P. W. Kalivas and J. Stewart Brain Res. Rev. 16 223 (1991). (10.1016/0165-0173(91)90007-U)
  3. 10.1007/BF00451687
  4. 10.1126/science.2781295
  5. T. E. Robinson and K. C. Berridge Brain Res. Rev. 18 247 (1993). (10.1016/0165-0173(93)90013-P)
  6. Wise R. A., Bozarth M. A., Psychol. Rev. 94, 469 (1987); (10.1037/0033-295X.94.4.469) / Psychol. Rev. by Wise R. A. (1987)
  7. Koob G. F., Bloom F. E., Science 242, 715 (1988). (10.1126/science.2903550) / Science by Koob G. F. (1988)
  8. 10.1523/JNEUROSCI.16-01-00274.1996
  9. Ortiz J., et al., Synapse 21, 289 (1995). (10.1002/syn.890210403) / Synapse by Ortiz J. (1995)
  10. Zhang X.-F., Hu X.-T., White F. J., Wolf M. E., J. Pharmacol. Exp. Ther. 281, 699 (1997). / J. Pharmacol. Exp. Ther. by Zhang X.-F. (1997)
  11. 10.1126/science.1709304
  12. Seeberg P., Trends Neurosci. 16, 359 (1993). (10.1016/0166-2236(93)90093-2) / Trends Neurosci. by Seeberg P. (1993)
  13. Karler R., Calder L. D., Turkanis S. A., Brain Res. 552, 295 (1991); (10.1016/0006-8993(91)90095-D) / Brain Res. by Karler R. (1991)
  14. ; Y. Li et al. Psychopharmacology in press.
  15. Locomotor activity was measured for 2 hours in circular chambers [
  16. Miserendino M. J. D., Guitart X., Terwilliger R. Z., Chi S., Nestler E. J., Mol. Cell. Neurosci. 4, 440 (1993); (10.1006/mcne.1993.1055) / Mol. Cell. Neurosci. by Miserendino M. J. D. (1993)
  17. ]. Male Sprague-Dawley rats (325 to 350 g) were screened with morphine because of within-strain differences in drug sensitivity [
  18. Deroche V., Piazza P. V., Le Moal M., Simon H., Brain Res. 623, 341 (1993); (10.1016/0006-8993(93)91451-W) / Brain Res. by Deroche V. (1993)
  19. ]. This low dose of morphine is not sufficient to cause statistically significant sensitization or to increase expression of GluR1 in the VTA (W. A. Carlezon Jr. et al. unpublished data) although small increases in activity can be observed with repeated treatment (for example Fig. 1A left).
  20. Rats were anesthetized (65 mg/kg sodium pentobarbital intraperitoneal) and given atropine (0.25 mg/kg s.c.) to minimize bronchial secretions. Unilateral microinjections (2.0 μl) of recombinants were delivered over 10 min into the VTA {relative to bregma: AP = −5.3 lat. = ±2.0 DV = 7.6 mm below dura [G. Paxinos and C. Watson The Rat Brain in Strereotaxic Coordinates (Academic Sydney Australia 1986)]}. The injection syringe was angled at 10° from the midline. For sham surgery the injection syringe was lowered 1 mm into the brain. Rats were retained if the microinjection site was within the VTA.
  21. cDNAs for GluR1i (flip) GluR2i and LacZ were inserted into the HSV amplicon HSVPrpUC and were packaged into virus with the helper 5 dl 1.2 (16). Virus was purified on a sucrose gradient pelleted and resuspended in 10% sucrose. Average titer of the recombinant virus stocks was 2.0 × 10 7 infectious units/ml; titers did not differ by more than 10% among preparations. Transgene expression was regulated by the constitutive promoter for the HSV immediate-early gene IE 4/5.
  22. VTAs were dissected from the injected hemisphere 4 days after vector microinjection; immunoblotting was done as described (5).
  23. Rats were overdosed with sodium pentobarbital and perfused with 0.9% saline followed by 4% paraformaldehyde; brains were kept overnight in 20% glycerol before slicing (40 μm or 20 μm for double-labeling). β-Galactosidase expression was examined as described [
  24. 10.1016/0169-328X(94)90011-6
  25. 10.2144/19962003460
  26. Jakowec M. W., Yen L.-H., Kalb R. G., Neuroscience 67, 904 (1995). / Neuroscience by Jakowec M. W. (1995)
  27. Neve R. L., Howe J. R., Hong S., Kalb R. G., ibid. 79, 435 (1997). (10.1103/PhysRevLett.79.435) / ibid. by Neve R. L. (1997)
  28. Berhow M. T., Hiroi N., Nestler E. J., J. Neurosci. 16, 4707 (1996). (10.1523/JNEUROSCI.16-15-04707.1996) / J. Neurosci. by Berhow M. T. (1996)
  29. Pruss R. M., Akeson R. L., Racke M. M., Wilburn J. L., Neuron 7, 509 (1991); (10.1016/0896-6273(91)90302-G) / Neuron by Pruss R. M. (1991)
  30. . Three days after surgery fresh VTA tissue was sliced on a vibratome (300 μm) and stimulated with kainate (250 μM) for 10 min.
  31. Immunohistochemical analyses for double-labeling of GluR1 and tyrosine hydroxylase were similar to those described [
  32. Berhow M. T., Hiroi N., Kobierski L. A., Hyman S. E., Nestler E. J., J. Neurosci. 16, 8019 (1996)]. (10.1523/JNEUROSCI.16-24-08019.1996) / J. Neurosci. by Berhow M. T. (1996)
  33. Immunohistochemical analysis for GluR2 (Chemicon GluR2/3; 1: 500) was similar to that described for GluR1 (16).
  34. Rewarding drugs establish conditioned place preferences [R. A. Wise in The Neuropharmacological Basis of Reward J. M. Liebman and S. J. Cooper Eds. (Oxford Univ. Press Oxford 1989)]. Place preference conditioning occurred in a three-compartment apparatus. On day 0 rats were allowed to freely explore the entire apparatus for 30 min; rats then received unilateral injections of an HSV vector or sham surgery. After 2 days' recovery conditioning trials (two per day) were given on two consecutive days (days 3 and 4). Rats first received saline (1 ml/kg s.c.) and were confined to a side compartment for 1 hour; 3 hours later rats received morphine (0.5 mg/kg s.c.) and were confined to the other side compartment for 1 hour. Compartments differed in floor texture wall patterns and lighting; rats do not show reliable baseline preferences for any compartment. On day 5 rats were allowed to freely explore the entire apparatus for 30 min. Rats with maximal transgene expression in the rostral VTA (from 4.7 to 5.3 mm posterior to bregma) were included.
  35. Galey D., Simon H., Le Moal M., Brain Res. 124, 83 (1977). (10.1016/0006-8993(77)90865-4) / Brain Res. by Galey D. (1977)
  36. M. J. During J. R. Naegele K. L. O'Malley
  37. Geller A. I., Science 266, 1399 (1994) . (10.1126/science.266.5189.1399) / Science by Geller A. I. (1994)
  38. Isacson O., ibid. 269, 856 (1995). / ibid. by Isacson O. (1995)
  39. Neve R. L., Geller A. I., Clin. Neurosci. 3, 1 (1996); / Clin. Neurosci. by Neve R. L. (1996)
  40. Fink D. J., DeLuca N. A., Goins W. F., Glorioso J. C., Annu. Rev. Neurosci. 19, 265 (1996). (10.1146/annurev.ne.19.030196.001405) / Annu. Rev. Neurosci. by Fink D. J. (1996)
  41. Bozarth M. A., Wise R. A., Life Sci. 28, 551 (1981). (10.1016/0024-3205(81)90148-X) / Life Sci. by Bozarth M. A. (1981)
  42. Self D. W., Nestler E. J., Annu. Rev. Neurosci. 18, 463 (1996); (10.1146/annurev.ne.18.030195.002335) / Annu. Rev. Neurosci. by Self D. W. (1996)
  43. Sklair-Tavron L., et al., Proc. Natl. Acad. Sci. U.S.A. 93, 11202 (1996). (10.1073/pnas.93.20.11202) / Proc. Natl. Acad. Sci. U.S.A. by Sklair-Tavron L. (1996)
  44. Segal D. S., Kuczenski R., Brain Res. 577, 351 (1992). (10.1016/0006-8993(92)90297-M) / Brain Res. by Segal D. S. (1992)
  45. Henry D. J., White F. J., J. Neurosci. 15, 6287 (1995). (10.1523/JNEUROSCI.15-09-06287.1995) / J. Neurosci. by Henry D. J. (1995)
  46. Supported by grants (to E.J.N.) and a fellowship (to W.A.C.) from the National Institute on Drug Abuse (USA) and grants (to R.G.K. and R.L.N.) from the National Institutes of Health. We thank N. Hiroi for his contributions.
Dates
Type When
Created 23 years, 1 month ago (July 27, 2002, 5:44 a.m.)
Deposited 1 year, 7 months ago (Jan. 13, 2024, 12:55 a.m.)
Indexed 1 year, 1 month ago (July 30, 2024, 3:49 p.m.)
Issued 28 years ago (Aug. 8, 1997)
Published 28 years ago (Aug. 8, 1997)
Published Print 28 years ago (Aug. 8, 1997)
Funders 0

None

@article{Carlezon_1997, title={Sensitization to Morphine Induced by Viral-Mediated Gene Transfer}, volume={277}, ISSN={1095-9203}, url={http://dx.doi.org/10.1126/science.277.5327.812}, DOI={10.1126/science.277.5327.812}, number={5327}, journal={Science}, publisher={American Association for the Advancement of Science (AAAS)}, author={Carlezon, William A. and Boundy, Virginia A. and Haile, Colin N. and Lane, Sarah B. and Kalb, Robert G. and Neve, Rachael L. and Nestler, Eric J.}, year={1997}, month=aug, pages={812–815} }